Asset Acquisitions and Disposals::Completion of Proposed Acquisition of the Tranche 2 Sale Shares of 17% in Ardence Pharma Sdn Bhd

Issuer & Securities

Issuer/ Manager
HYPHENS PHARMA INTERNATIONAL LIMITED
Securities
HYPHENS PHARMA INTL LIMITED - SG1EE4000006 - 1J5
Stapled Security
No

Announcement Details

Announcement Title
Asset Acquisitions and Disposals
Date &Time of Broadcast
09-May-2025 17:25:42
Status
New
Announcement Sub Title
Completion of Proposed Acquisition of the Tranche 2 Sale Shares of 17% in Ardence Pharma Sdn Bhd
Announcement Reference
SG250509OTHR4202
Submitted By (Co./ Ind. Name)
Lim See Wah
Designation
Executive Chairman and CEO
Description (Please provide a detailed description of the event in the box below)
Please refer to the attached.

This announcement has been reviewed by the Company's sponsor, SAC Capital Private Limited (the "Sponsor"). This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited ("SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms. Lee Khai Yinn (Telephone: +65 6232 3210) at 1 Robinson Road, #21-01 AIA Tower, Singapore 048542

Attachments

Hyphens Pharma - Ardence Pharma announcement - Tranche 2 Completion.pdf
Total size =208K